J&J’s cardiovascular business boosts medtech growth in 2025
强生强生(US:JNJ) Yahoo Finance·2026-01-21 20:11

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers   2025 medtech sales: 33.79billion6.133.79 billion 6.1% growth year over year   Cardiovascular sales: 8.93 billion 15.8% growth year over year   Orthopedic sales: $9.26 billion 1.1% growth year over year Johnson & Johnson’s cardiovascular segment fueled strong sales growth for the healthcare giant’s medical device business in 2025. The cardiovascular bus ...

J&J’s cardiovascular business boosts medtech growth in 2025 - Reportify